October 2018

Editor-in-chief, Jason C. Gallagher, PharmD, FCCP, FIDSA, BCPS, shares how it is up to all of us in health care to evaluate the level of evidence in our practices and continue to evolve, just like the organisms we work to treat.

This case report is the fourth documented case of Lyme-induced syndrome of inappro­priate secretion of antidiuretic hormone (SIADH).

The virus may be fading from mainstream headlines, but it is active and physicians must stay vigilant.

Key considerations when choosing a treatment for gram-negative nosocomial infections include the patient’s referring facility.

The clinical characteristics and outcomes of Pneumocystis jirovecii pneumonia differ in immunocompromised patients with and without HIV.

The globalization of antibiotic stewardship programs is necessary in the fight against antibiotic resis­tance.

Hospital-acquired and ventilator-associated pneumonia account for 22% of all hospital-acquired infections.

Revised DHHS and IAS–USA guidelines provide new insight for physicians managing patients with HIV.

As knowledge and awareness of rising antimicrobial resistance increase, clinicians must continue to adopt strategies for improving antibiotic use.

The drug presents a new option for patients at high risk of infections caused by organisms, such as carbapenem-resistant Enterobacteriaceae.